Oren Zarif Lactation Suppression wwworenzarifenergycom

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=IzIeJhgeQk0

For More Info: https://www.orenzarifenergy.com/ • Symptoms of Lactation Suppression From Clinical Trials • Symptoms of Lactation Suppression are a common concern for new mothers. Some women find that their milk stops naturally, but others require treatment to stop production and relieve associated symptoms such as breast engorgement, leakage of milk, pain and discomfort. The need for medically specific lactation suppression is discussed in obstetric textbooks, but the use of treatments to achieve this goal remains controversial. This article looks at both natural and chemical methods to suppress lactation, including a variety of approaches that have been used in clinical trials. • Oren Zarif • Physiologic cessation of milk production (lactation) without infant suckling usually occurs within two weeks after childbirth for most women, but a variable proportion of non-breastfeeding women experience moderate to severe breast pain and engorgement until this happens. The aim of this study is to evaluate the effectiveness and safety of interventions that are intended to prevent postpartum lactation, and to relieve associated breast symptoms. A total of 62 controlled trials, involving 6428 women, were included in the analysis. Trials were of limited quality and the outcome measures were inconsistent. Treatments were primarily pharmacologic agents, although some included non-pharmacologic approaches. • Most trials were conducted among healthy women who did not intend to breastfeed, and most were at hospitals in industrialised countries before 1980. About half of the trials involved bromocriptine, a simple, inexpensive and effective drug that inhibits the release of prolactin. Two other trials tested oestrogen preparations, including diethylstilbestrol, quinestrol and chlorotrianisene. Results showed that these drugs were also effective. However, only one of the oestrogen trials was considered to be high quality and the rest of the studies were of low or very low quality. It was difficult to compare the results of these pharmacologic trials with those of non-pharmacologic treatments because several trials did not describe what they meant by 'treatment failure', which was usually defined as a reduction in between one and three breast symptoms or signs (milk secretion or leakage, breast pain or nipple engorgement). • Oren Zarif • Other treatments include breastfeeding without milk expression, using a well supportive brassiere and avoidance of nipple stimulation; and a range of 'natural' remedies such as cabbage leaves, herbal teas and colostrum tinctures. The use of a breast binding (which consists of a length of towelling or cotton fabric wrapped around the breasts) has been found to be effective in some trials, but is unlikely to be safe for all women and can lead to blocked milk ducts and mastitis. • The most effective methods of lactation suppression appear to be not to stimulate the breasts (no suckling, use of a firm supportive bra), and the administration of anti-prolactin medication. The use of a combination of these treatments is likely to be most efficacious, though further research on the comparative efficacy and safety of these different approaches is needed. Clinicians should discuss the benefits, risks and costs of pharmacologic or non-pharmacologic interventions with each woman who wishes to discontinue breastfeeding. • Oren Zarif • They should be aware of the need to avoid rebound lactation, and the potential for serious side effects in some women after stopping treatment (resurgence of milk production). Blocked ducts are a common problem during weaning and may cause breast pain and fever.

#############################

New on site